PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
5.38 - 5.60
4.95 - 8.28
2.3K / 2.4K (Avg.)
-279.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-8.41%
Negative revenue growth while UPM.HE stands at 2.36%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-7.38%
Negative gross profit growth while UPM.HE is at 15.19%. Joel Greenblatt would examine cost competitiveness or demand decline.
18.84%
EBIT growth similar to UPM.HE's 19.48%. Walter Schloss might infer both firms share similar operational efficiencies.
18.84%
Operating income growth similar to UPM.HE's 19.48%. Walter Schloss would assume both share comparable operational structures.
37.56%
Net income growth above 1.5x UPM.HE's 21.19%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
33.33%
EPS growth above 1.5x UPM.HE's 22.00%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
33.33%
Diluted EPS growth above 1.5x UPM.HE's 22.00%. David Dodd would see if there's a robust moat protecting these shareholder gains.
3.17%
Share change of 3.17% while UPM.HE is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
3.17%
Diluted share change of 3.17% while UPM.HE is zero. Bruce Berkowitz might see a minor difference that could widen over time.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
48.48%
OCF growth above 1.5x UPM.HE's 31.61%. David Dodd would confirm a clear edge in underlying cash generation.
90.35%
FCF growth above 1.5x UPM.HE's 45.02%. David Dodd would verify if the firm’s strategic investments yield superior returns.
-32.26%
Negative 10Y revenue/share CAGR while UPM.HE stands at 8.52%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-5.25%
Negative 5Y CAGR while UPM.HE stands at 6.17%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-11.00%
Negative 3Y CAGR while UPM.HE stands at 4.78%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-29.11%
Negative 10Y OCF/share CAGR while UPM.HE stands at 141.25%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
520.62%
5Y OCF/share CAGR above 1.5x UPM.HE's 49.95%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
-45.68%
Negative 3Y OCF/share CAGR while UPM.HE stands at 19.32%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
166.67%
Below 50% of UPM.HE's 469.60%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
700.00%
5Y net income/share CAGR above 1.5x UPM.HE's 133.97%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
100.00%
Positive short-term CAGR while UPM.HE is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
54.65%
5Y equity/share CAGR above 1.5x UPM.HE's 22.80%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
16.80%
3Y equity/share CAGR similar to UPM.HE's 15.61%. Walter Schloss sees both having parallel profitability or reinvestment over 3 years.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-6.70%
Firm’s AR is declining while UPM.HE shows 3.56%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
3.35%
Inventory growth well above UPM.HE's 6.12%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
3.19%
Asset growth 1.25-1.5x UPM.HE's 2.61%. Bruce Berkowitz sees if the firm's investments effectively outpace the competitor in future returns.
4.43%
75-90% of UPM.HE's 5.19%. Bill Ackman advocates improvements in profitability or buybacks to keep pace in net worth growth.
-2.92%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-9.45%
We cut SG&A while UPM.HE invests at 0.00%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.